Memantine Teva Sante

Memantine Hydrochloride, the active ingredient in Memantine Teva Sante, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adult patients.

GNH USA supplies Memantine Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine Teva Sante is an NMDA‑receptor antagonist used in the management of Alzheimer’s disease. - Mild to moderate Alzheimer’s disease: improves cognition, memory and daily functional abilities. - Moderate to severe Alzheimer’s disease: provides modest cognitive benefit, often used in combination with cholinesterase inhibitors. - Adjunct therapy in Alzheimer’s disease: may enhance overall treatment response when added to standard care.

Memantine Teva Sante may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Confusion: temporary mental clouding. - Fatigue: feeling unusually tired. - Hypertension: elevated blood pressure readings.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing, rash. - Stevens‑Johnson syndrome: painful skin blistering and detachment. - Seizures: rare occurrence of convulsive episodes. - Hallucinations or psychosis: visual or auditory disturbances. - Significant liver enzyme elevation: abnormal liver function tests. - Persistent vomiting: ongoing nausea and emesis.

When prescribing Memantine Teva Sante, clinicians should consider several safety aspects. - Renal impairment: adjust dose or monitor renal function closely. - Hepatic impairment: use with caution and monitor liver enzymes. - History of seizures: observe for increased seizure activity. - Concomitant NMDA antagonists: avoid additive neuro‑psychiatric effects. - Pregnancy and breastfeeding: limited data, use only if benefit outweighs risk. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Memantine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism can increase CNS side effects. - Other NMDA antagonists (e.g., ketamine): risk of excessive receptor blockade. - Strong CYP450 inhibitors (e.g., quinidine): may raise memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinesterase inhibitors (donepezil, rivastigmine): monitor for additive cognitive effects. - Diuretics (furosemide): may affect renal clearance of memantine. - Antihypertensive agents: potential enhancement of blood‑pressure‑lowering effects. - Antipsychotics: watch for increased confusion or sedation. - Anticonvulsants: possible alteration of seizure threshold.